The Targeted Pathogen Microbial Testing program includes Targeted Pathogen Microbial Testing (DNA) and Targeted Pathogen Microbial Testing Upgraded Version (DNA+RNA). Targeted Pathogen Microbial Test (DNA) covers 90 drug-resistant genes and 176 pathogens in the clinic. The second-generation sequencing Targeted Pathogen Microbial Test can find the cause of infections with unclear etiology, and can be used as a reference for antimicrobial drugs used in the clinic. The upgraded version of Targeted Pathogenic Microbial Test (DNA+RNA) covers 90 drug-resistant genes and 221 pathogens in the clinic, and the second generation sequencing Targeted Pathogenic Microbial Test can also be used to find out the cause of infections with unclear etiology, and can be used as a reference for the antimicrobial drugs used in the clinic. Targeted pathogenic microbial testing program and the center’s original PCR and mass spectrometry detection technology platform, pathogen macro genome detection (mNGS) platform, fully automated pipeline microbial culture and drug sensitivity identification technology platform, immunological detection technology platform and other platforms, to achieve a comprehensive diagnosis of infectious diseases. It is recommended to go to regular hospitals for examination.